Regional tenders on biosimilars in Italy: An empirical analysis of awarded prices

Discussion: Our analysis confirms the theory that worthwhile savings can be generated in tenders, once the bid is designed in such a way that competition can produce its effects, i.e. allowing more than one manufacturer to tender. However, most of the Italian regional tenders on off-patent bioagents do not seem to exploit potential competition to the full.

Source: Health Policy - March 6, 2014 Category: Health Management Authors: Sandro Curto, Simone Ghislandi, Katelijne van de Vooren, Silvy Duranti, Livio Garattini Tags: Pharmaceutical policies and their effects Source Type: research